PMID- 7755916 OWN - NLM STAT- MEDLINE DCOM- 19950627 LR - 20131121 IS - 0269-9370 (Print) IS - 0269-9370 (Linking) VI - 9 IP - 3 DP - 1995 Mar TI - Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. PG - 275-80 AB - OBJECTIVE: To assess the association between human leukocyte antigen (HLA) haplotypes and the incidence rates of CD4 decline to < 20% and to AIDS. DESIGN: Retrospective cohort study of 95 HIV-1-infected hemophilic sibling pairs. METHODS: HLA haplotype-sharing between siblings was assigned on the basis of serologic typing of HLA class I alleles and molecular typing of HLA class II alleles. Concordance of time to CD4 decline to < 20% and to AIDS within and between sibling pairs was assessed by analysis of variance models and calculations of intraclass correlation coefficients. The age-adjusted relative risks of these two endpoints for unique class II haplotypes were determined from proportional hazards models. RESULTS: Sibling pairs sharing one or two haplotypes were significantly concordant in CD4 decline and AIDS status within 5 years of seroconversion. No concordance was found in pairs sharing zero haplotypes. At 6-10 years after seroconversion, significant concordance of these two endpoints was also observed in the pairs sharing one haplotype. The concordant results were not explained by the use of zidovudine within the pairs. Among the individuals in this cohort, the relative hazards for CD4 decline to < 20% and for AIDS were significantly elevated for one class II haplotype (DQB1*0501, DQA1*0101, DRB1*0101). In addition, the risk for AIDS was significantly increased for two other class II haplotypes (DQB1*0603, DQA1*0103, DRB1*1300, DRB3*0202 and DQB1*0301, DQA1*0501, DRB1*1400, DRB3*0202) and significantly decreased for one haplotype (DQB1*0302, DQA1*0301, DRB1*0401, DRB4*0101). CONCLUSIONS: These data demonstrate that HIV-1 disease progression is associated with the genes in the major histocompatibility complex that regulate the host's immune response. FAU - Kroner, B L AU - Kroner BL AD - Epidemiologic and Medical Studies Program, Research Triangle Institute, Rockville, MD 20852, USA. FAU - Goedert, J J AU - Goedert JJ FAU - Blattner, W A AU - Blattner WA FAU - Wilson, S E AU - Wilson SE FAU - Carrington, M N AU - Carrington MN FAU - Mann, D L AU - Mann DL LA - eng GR - N01-CP-33002/CP/NCI NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - AIDS JT - AIDS (London, England) JID - 8710219 RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Histocompatibility Antigens Class II) RN - 4B9XT59T7S (Zidovudine) SB - IM MH - Acquired Immunodeficiency Syndrome/*complications/drug therapy/epidemiology/physiopathology MH - Age Factors MH - Analysis of Variance MH - *CD4 Lymphocyte Count MH - Cohort Studies MH - Disease Progression MH - Genes, MHC Class I MH - Genes, MHC Class II MH - HIV Seropositivity MH - *HIV-1 MH - Haplotypes MH - Hemophilia A/*complications MH - Histocompatibility Antigens Class I/*blood MH - Histocompatibility Antigens Class II/*blood MH - Humans MH - Incidence MH - *Nuclear Family MH - Proportional Hazards Models MH - Retrospective Studies MH - Zidovudine/therapeutic use EDAT- 1995/03/01 00:00 MHDA- 1995/03/01 00:01 CRDT- 1995/03/01 00:00 PHST- 1995/03/01 00:00 [pubmed] PHST- 1995/03/01 00:01 [medline] PHST- 1995/03/01 00:00 [entrez] PST - ppublish SO - AIDS. 1995 Mar;9(3):275-80.